Home › Funds › DCF Advisers, LLC › IMRX
DCF Advisers, LLC position in IMRX
IMMUNEERING CORP · Health Care
DCF Advisers, LLC reported holding 862,500 shares of IMRX (IMMUNEERING CORP) in its Q3 2026 13F filing — a position valued at US$3.5M, representing 1.04% of its reported portfolio and ranking #21 among its reported holdings. DCF Advisers, LLC has disclosed IMRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How DCF Advisers, LLC's IMRX position evolved
DCF Advisers, LLC first disclosed a stake in IMRX in Q3 2025 at 147,000 shares (US$1.0M). The position peaked in Q2 2026 at 790,000 shares, worth US$3.9M. Across 5 filings, DCF Advisers, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 862,500 shares valued at US$3.5M — an increase of 72,500 shares quarter over quarter.. Notable position changes include a 46% increase in Q4 2025 (shares fell 20% over the following quarter), a 34% trim in Q1 2026 (shares fell 5% over the following quarter), a 458% increase in Q2 2026 (shares fell 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 147.00K | $1.03M | New |
| Q4 2025 | 215.00K | $1.41M | Add |
| Q1 2026 | 141.46K | $745.50K | Reduce |
| Q2 2026 | 790.00K | $3.94M | Add |
| Q3 2026 | 862.50K | $3.53M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMRX and 13F data
IMRX (IMMUNEERING CORP) is a Health Care company. 51 other funds we track also report a position in IMRX — the largest reported positions include Sanofi (US$11.1M), ALETHEA CAPITAL MANAGEMENT, LLC (US$1.9M), Occam Crest Management LP (US$1.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMRX
- Sanofi 2.71M sh · $11.09M · Q3 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 472.94K sh · $1.94M · Q3 2026
- Occam Crest Management LP 278.50K sh · $1.13M · Q2 2026
- BRANDYWINE MANAGERS, LLC 55.07K sh · $274.78K · Q2 2026
More on DCF Advisers, LLC
FAQ
How long has DCF Advisers, LLC held IMRX?
DCF Advisers, LLC has disclosed IMRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is DCF Advisers, LLC's current position in IMRX?
As of Q3 2026, DCF Advisers, LLC holds 862.50K shares of IMRX (IMMUNEERING CORP), valued at $3.53M, representing 1.04% of its reported portfolio and ranking #21.
Has DCF Advisers, LLC been buying or selling IMRX?
In the latest 13F filing (Q3 2026), DCF Advisers, LLC increased its position in IMRX. The position peaked in Q2 2026 at 790.00K shares.
Which other funds hold IMRX?
Other major institutional holders of IMRX include Sanofi, ALETHEA CAPITAL MANAGEMENT, LLC, Occam Crest Management LP, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.